Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

XERS Xeris Pharmaceuticals

1.560
-0.030-1.89%
Close 09/30 16:00 ET
1.5600.0000.00%
Post Mkt Price 09/30 16:02 ET
High
1.650
Open
1.570
Turnover
775.06K
Low
1.550
Pre Close
1.590
Volume
488.17K
Market Cap
212.09M
P/E(TTM)
Loss
52wk High
3.169
Shares
135.96M
P/E(Static)
Loss
52wk Low
1.250
Float Cap
189.39M
Bid/Ask %
-66.67%
Historical High
27.983
Shs Float
121.40M
Volume Ratio
0.73
Historical Low
1.250
Dividend TTM
--
Div Yield TTM
--
P/B
2.87
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.40%
Amplitude
6.29%
Avg Price
1.587
Lot Size
1
Float Cap
189.39M
Bid/Ask %
-66.67%
Historical High
27.983
Shs Float
121.40M
Volume Ratio
0.73
Historical Low
1.250
Dividend TTM
--
P/B
2.87
Dividend LFY
--
Turnover Ratio
0.40%
Amplitude
6.29%
Avg Price
1.587
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL.
CEO: Mr. Paul R. Edick
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...